Jennifer Gabler

Jennifer Gabler

Signal active

Chief Financial Officer

Bio

Jennifer Gabler is the Chief Financial Officer at EvolveImmune Therapeutics.

Location

New York, New York, United States, North America

Social

Primary Organization

EvolveImmune Therapeutics

EvolveImmune Therapeutics

Founded

2020

Employees

11-50

Industry

Biotechnology, Health Care, Medical, Therapeutics, Oncology

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Jennifer Gabler is the Chief Financial Officer at EvolveImmune Therapeutics, based in New York, New York, United States, North America. With a background in Biotechnology, Jennifer Gabler has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

0

There is no partner investment available on this profile

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity